A Dark Vector Cognition product

Item 6. Exhibits

3K characters. Original on sec.gov · Markdown

Item 6. Exhibits

​​​
​​​
3.1​Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the
​​Quarterly Report on Form 10-Q, filed August 9, 2022)
3.2​Bylaws, as amended and restated (incorporated by reference to Exhibit 3.2 to the Quarterly Report on Form 10-Q, filed August 9, 2022)
31.1*​Principal Executive Officer Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a)
31.2*​ ​Principal Financial Officer Certification pursuant to Rule 13a-14(a) or Rule 15d-14(a)
32**​Principal Executive Officer and Principal Financial Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*​Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH*​Inline XBRL Taxonomy Extension Schema Document
101.CAL*​Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF*​Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB*​Inline XBRL Taxonomy Extension Label Linkbase Document ​
101.PRE*​Inline XBRL Taxonomy Extension Presentation Linkbase Document
104*​The cover page from the Company’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL
​​​
​​​

​

+Management contract or compensatory plan or arrangement

  • Filed herewith

** Furnished herewith

​

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

AXON ENTERPRISE, INC.​​
​​​​
Date:August 8, 2023​​
​​By:/s/ PATRICK W. SMITH
​​​Chief Executive Officer
​​​(Principal Executive Officer)
​​​
Date:August 8, 2023By:/s/ BRITTANY BAGLEY
​​​Chief Operating Officer and Chief Financial Officer
​​​(Principal Financial and
​​​Accounting Officer)

​

​

​

​

​

Previous: Item 5. Other Information